ERBB2 and breast cancer: Similarly, analysis of the BC subgroups demonstrated that the CCRG set was significantly highly expressed in the four BC subtypes (luminal A, luminal B, HER2-positive and triple-negative (TNBC)) (p<0.05, Figure 4B).